Find a Supplier
Add Company
enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project
Contact Us Subscribe to Newsletter
Contact Supplier

Contact Supplier

To get in touch with enGenes Biotech GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project

    enGenes Biotech GmbH News Releases

    Find the latest News from enGenes Biotech GmbH

    Page 1 of 3
    enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project
    enGenes secure significant funding for ECOnti E. coli Continuous Manufacturing Project

    Wednesday 3rd May 2023

    By  enGenes Biotech… Learn More >
    enGenes Biotech to make debut at Swiss Biotech Day conference
    enGenes Biotech to make debut at Swiss Biotech Day conference

    Tuesday 18th April 2023

    By  enGenes Biotech… Learn More >
    Study indicates enGenes Biotech’s Shiga Toxin B subunits useful as drug carriers in cancer therapy
    Study indicates enGenes Biotech’s Shiga Toxin B subunits useful as drug carriers in cancer therapy

    Monday 10th April 2023

    By  enGenes Biotech… Learn More >
    enGenes Biotech bringing enhanced product yield opportunities to BIO-Europe Autumn in Germany
    enGenes Biotech bringing enhanced product yield opportunities to BIO-Europe Autumn in Germany

    Friday 21st October 2022

    By  enGenes Biotech… Learn More >
    enGenes Biotech makes debut at ICB V continuous biomanufacturing event
    enGenes Biotech makes debut at ICB V continuous biomanufacturing event

    Wednesday 5th October 2022

    By  enGenes Biotech… Learn More >
    enGenes Biotech to showcase enzyme production offers at Chemspec Europe
    enGenes Biotech to showcase enzyme production offers at Chemspec Europe

    Tuesday 24th May 2022

    By  enGenes Biotech… Learn More >
    enGenes participates in the study of large scale production strategies for microbial carbohydrate-binding toxins
    enGenes participates in the study of large scale production strategies for microbial carbohydrate-binding toxins

    Wednesday 18th May 2022

    By  enGenes Biotech… Learn More >
    enGenes Biotech joins TU Munich to study cost-effective protein purification by magnetic nanoparticles
    enGenes Biotech joins TU Munich to study cost-effective protein purification by magnetic nanoparticles

    Tuesday 15th March 2022

    By  enGenes Biotech… Learn More >
    enGenes presenting X-cite Continuous Manufacturing technology to EFIB 2021 Vienna
    enGenes presenting X-cite Continuous Manufacturing technology to EFIB 2021 Vienna

    Wednesday 22nd September 2021

    By  enGenes Biotech… Learn More >
    enGenes X-press achieves high yield SARS CoV-2 nucleocapsid protein expression
    enGenes X-press achieves high yield SARS CoV-2 nucleocapsid protein expression

    Thursday 26th August 2021

    By  enGenes Biotech… Learn More >
    Studies confirm usefulness of enGenes Biotech’s high quality SARS CoV-2 antigens
    Studies confirm usefulness of enGenes Biotech’s high quality SARS CoV-2 antigens

    Tuesday 20th April 2021

    By  enGenes Biotech… Learn More >
    New study shows ecological benefits for enGenes Biotech X-press technology
    New study shows ecological benefits for enGenes Biotech X-press technology

    Thursday 4th March 2021

    By  enGenes Biotech… Learn More >
    Page 1 of 3
    Full Supplier Profile